Basit öğe kaydını göster

dc.contributor.authorMentese, Ahmet
dc.contributor.authorAlver, Ahmet
dc.contributor.authorDemir, Selim
dc.contributor.authorSümer, Ayşegül
dc.contributor.authorÖzer Yaman, Serap
dc.contributor.authorKarkucak, Murat
dc.contributor.authorAydın Çapkın, Arzu
dc.contributor.authorUs Altay, Diler
dc.contributor.authorTuran, İbrahim
dc.date.accessioned2020-12-19T19:49:28Z
dc.date.available2020-12-19T19:49:28Z
dc.date.issued2017
dc.identifier.citationMentese, A., Alver, A., Demir, S., Sumer, A., Ozer Yaman, S., Karkucak, M., Aydin Capkin, A., Us Altay, D., & Turan, I. (2017). Carbonic anhydrase I and II autoantibodies in Behçet's disease. Carbonic anhydrase I and II autoantibodies in Behçet’s disease. Acta reumatologica portuguesa, 42(1), 26–31.en_US
dc.identifier.issn0303-464X
dc.identifier.urihttps://hdl.handle.net/11436/2289
dc.descriptionDemir, Selim/0000-0002-1863-6280;en_US
dc.descriptionWOS: 000398616200004en_US
dc.descriptionPubMed: 28198796en_US
dc.description.abstractBackground: Behcet's disease ( BD) is a vasculitis, seen more frequently around the Mediterranean and the Far East, and evinces with oral and genital ulcerations, skin lesions and uveitis. Carbonic anhydrase ( CA) is a metalloenzyme which is widely distributed in the living world, and it is essential for the regulation of acid-base balance. Anti-CA antibodies have been reported in many disorders, such as systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, endometriosis, idiopathic chronic pancreatitis, type 1 diabetes and Graves' disease. the goal of this study was to investigate CA I and II autoantibodies in BD. Methods: 35 patients with BD and 29 healthy controls were included in the study and CA I and II autoantibody levels were investigated by ELISA. Results: the CA I and II autoantibody levels of BD group were significantly higher than the healthy group (p= 0.013, p= 0.0001, respectively). A cut-off value of 0.250 absorbance unit (ABSU) for anti-CA I was associated with 34% sensitivity and 100% specificity and a cut-off value of 0.171 ABSU for anti-CA II was associated with 54% sensitivity and 100% specificity for predicting BD. Conclusion: the CA I and II autoantibody levels in pa-tients with BD were found higher compared to control group and the results suggest that CA I and II autoantibodies may be involved in the pathogenesis of BDen_US
dc.language.isoengen_US
dc.publisherPublisaude-Edicoes Medicas Ldaen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAutoantibodyen_US
dc.subjectBehcet's diseaseen_US
dc.subjectCarbonic anhydraseen_US
dc.titleCarbonic anhydrase I and II autoantibodies in Behcet's diseaseen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorSümer, Ayşegül
dc.identifier.volume42en_US
dc.identifier.issue1en_US
dc.identifier.startpage26en_US
dc.identifier.endpage31en_US
dc.ri.editoaen_US
dc.relation.journalActa Reumatologica Portuguesaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster